Health and wellness marketing agency Fingerpaint (Saratoga Springs, NY) has acquired 1798, a market access and commercialization firm located in La Jolla, CA.
1798’s 60-person team specializes in developing tailored market access and commercialization support programs for drugs at any stage in the product life cycle. Fingerpaint founder Ed Mitzen commented: “With the acquisition of 1798, Fingerpaint will be able to assure our life sciences clients that we can provide the full continuum of market access planning and commercialization support services to successfully assist them in building their brands and launching new products.”
Terms of the deal were not disclosed.
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
Efsitora Demonstrates Non-Inferiority vs. Insulin Glargine, Degludec for Type 2 Diabetes
September 5th 2024Results from the QWINT-1 and QWINT-3 trials found that insulin-naïve patients achieved similar reductions in A1C levels using once-weekly efsitora compared to daily insulin glargine and degludec.